Experimental Hematology
Volume 38, Issue 2 , Pages 132-140, February 2010

GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche

Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Mich., USA

Received 4 August 2009; received in revised form 3 November 2009; accepted 9 November 2009. published online 16 November 2009.

Objective

Despite improvements in current combinational chemotherapy regimens, the prognosis of the (1;19)(q23;p13) translocation (E2A/PBX1)−positive B-cell precursor acute lymphoblastic leukemia (ALL) is poor in pediatric leukemia patients.

Materials and Methods

In this study, we examined the roles of growth arrest−specific-6 (GAS6)/Mer axis in the interactions between E2A/PBX1-positive B-cell precursor ALL cells and the osteoblastic niche in the bone marrow.

Results

Data show that primary human osteoblasts secrete GAS6 in response to the Mer-overexpressed E2A/PBX1-positive ALL cells through mitogen-activated protein kinase signaling pathway and that leukemia cells migrate toward GAS6 using pathways activated by Mer. Importantly, GAS6 supports survival and prevents apoptosis from chemotherapy of E2A/PBX1-positive ALL cells by inducing dormancy.

Conclusions

These data suggest that GAS6/Mer axis regulates homing and survival of the E2A/PBX1-positive B-cell precursor ALL in the bone marrow niche.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0301-472X(09)00427-5

doi:10.1016/j.exphem.2009.11.002

Experimental Hematology
Volume 38, Issue 2 , Pages 132-140, February 2010